{"_buckets": {"deposit": "a3abc4d8-b3d6-4f4a-800c-810b324b830e"}, "_deposit": {"id": "3895", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "3895"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00003895", "sets": ["462"]}, "author_link": ["7822", "7823", "7824", "7825", "7826", "7827"], "item_1628147817048": {"attribute_name": "出版タイプ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_6_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2009", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3", "bibliographicPageEnd": "180", "bibliographicPageStart": "178", "bibliographicVolumeNumber": "16", "bibliographic_titles": [{"bibliographic_title": "Amyloid-Journal of Protein Folding Disorders"}]}]}, "item_6_description_19": {"attribute_name": "内容記述", "attribute_value_mlt": [{"subitem_description": "This is an electronic version of an article published in Amyloid 2009, Vol. 16, No. 3 : Pages 178-180. Amyloid is available online at: http://informahealthcare.com/doi/pdf/10.1080/13506120903090940", "subitem_description_type": "Other"}]}, "item_6_description_20": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "We report a patient with AH amyloidosis associated with lymphoplasmacytic leukemia that has remained in a stable state with a nephrotic syndrome for 17 months since the commencement of cyclic rituximab therapy aimed at suppression of pathogenetic gamma heavy chains. Free light chains in serum and CD20-positive cells in peripheral blood were useful as hematological markers in the patient. Rituximab might be a potent therapeutic option for AH amyloidosis associated with a B-cell lymphoproliferative disorder.", "subitem_description_type": "Abstract"}]}, "item_6_description_30": {"attribute_name": "資源タイプ（コンテンツの種類）", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_31": {"attribute_name": "フォーマット：mimeタイプ", "attribute_value_mlt": [{"subitem_description": "application/pdf", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "AMYLOID. 16(3):178-180 (2009)", "subitem_description_type": "Other"}]}, "item_6_link_3": {"attribute_name": "信州大学研究者総覧へのリンク", "attribute_value_mlt": [{"subitem_link_text": "Katoh, Nagaaki", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.yFTpgpkh.html"}, {"subitem_link_text": "Yazaki, Masahide", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.gpTauakh.html"}]}, "item_6_link_67": {"attribute_name": "WoS", "attribute_value_mlt": [{"subitem_link_text": "Web of Science", "subitem_link_url": "http://gateway.isiknowledge.com/gateway/Gateway.cgi?\u0026GWVersion=2\u0026SrcAuth=ShinshuUniv\u0026SrcApp=ShinshuUniv\u0026DestLinkType=FullRecord\u0026DestApp=WOS\u0026KeyUT=000270909300008"}]}, "item_6_publisher_4": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "INFORMA HEALTHCARE"}]}, "item_6_relation_47": {"attribute_name": "PubMed", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "19590993"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://pubmed.ncbi.nlm.nih.gov/19590993", "subitem_relation_type_select": "PMID"}}]}, "item_6_relation_48": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1080/13506120903090940"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1080/13506120903090940", "subitem_relation_type_select": "DOI"}}]}, "item_6_select_64": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "author"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1350-6129", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1350-6129", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_40": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AA11096426", "subitem_source_identifier_type": "NCID"}]}, "item_6_text_69": {"attribute_name": "wosonly authkey", "attribute_value_mlt": [{"subitem_text_value": "AH amyloidosis; nephrotic syndrome; B-cell lymphoproliferative disorder; rituximab"}]}, "item_6_text_70": {"attribute_name": "wosonly keywords", "attribute_value_mlt": [{"subitem_text_value": "IMMUNOGLOBULIN HEAVY-CHAIN; MONOCLONAL-ANTIBODY; LIGHT-CHAIN; LYMPHOMA; FRAGMENT"}]}, "item_6_textarea_68": {"attribute_name": "wosonly abstract", "attribute_value_mlt": [{"subitem_textarea_value": "We report a patient with AH amyloidosis associated with lymphoplasmacytic leukemia that has remained in a stable state with a nephrotic syndrome for 17 months since the commencement of cyclic rituximab therapy aimed at suppression of pathogenetic gamma heavy chains. Free light chains in serum and CD20-positive cells in peripheral blood were useful as hematological markers in the patient. Rituximab might be a potent therapeutic option for AH amyloidosis associated with a B-cell lymphoproliferative disorder."}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Katoh,  Nagaaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "7822", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Matsuda,  Masayuki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "7823", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Miyazaki,  Daigo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "7824", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Gono,  Takahisa", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "7825", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yazaki,  Masahide", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "7826", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ikeda,  Shu-ichi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "7827", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2015-09-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "Rituximab_therapy_nephrotic_syndrome.pdf", "filesize": [{"value": "124.6 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 124600.0, "url": {"label": "Rituximab_therapy_nephrotic_syndrome.pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/3895/files/Rituximab_therapy_nephrotic_syndrome.pdf"}, "version_id": "dda89d9e-9739-4004-98ac-f56bb5ff20b3"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "AH amyloidosis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "nephrotic syndrome", "subitem_subject_scheme": "Other"}, {"subitem_subject": "B-cell lymphoproliferative disorder", "subitem_subject_scheme": "Other"}, {"subitem_subject": "rituximab", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Rituximab therapy in nephrotic syndrome due to AH amyloidosis", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Rituximab therapy in nephrotic syndrome due to AH amyloidosis", "subitem_title_language": "en"}]}, "item_type_id": "6", "owner": "1", "path": ["462"], "permalink_uri": "http://hdl.handle.net/10091/11069", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2011-01-12"}, "publish_date": "2011-01-12", "publish_status": "0", "recid": "3895", "relation": {}, "relation_version_is_last": true, "title": ["Rituximab therapy in nephrotic syndrome due to AH amyloidosis"], "weko_shared_id": -1}